<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7318922\results\search\disease\results.xml">
  <result pre="a range of diseases from the common cold to severe" exact="acute" post="and Middle East respiratory syndrome CoV epidemics. In 2019,"/>
  <result pre="from the common cold to severe acute and Middle East" exact="respiratory" post="syndrome CoV epidemics. In 2019, a novel virus emerged"/>
  <result pre="the common cold to severe acute and Middle East respiratory" exact="syndrome" post="CoV epidemics. In 2019, a novel virus emerged from"/>
  <result pre="Wuhan, China, and resulted in a marked worldwide outbreak of" exact="respiratory" post="illness. Prevention and containment became the prioritized intervention against"/>
  <result pre="COVID-19, coupled with a continued search for hallmarks of the" exact="disease" post="that would allow early detection and provide insight into"/>
  <result pre="allow early detection and provide insight into management and triage." exact="Cutaneous" post="findings associated with COVID-19 include diffuse maculopapular rashes, livedo"/>
  <result pre="into management and triage. Cutaneous findings associated with COVID-19 include" exact="diffuse" post="maculopapular rashes, livedo reticularis, and acro-ischemic â€œCOVID toes.â€� These"/>
  <result pre="triage. Cutaneous findings associated with COVID-19 include diffuse maculopapular rashes," exact="livedo reticularis," post="and acro-ischemic â€œCOVID toes.â€� These skin findings occurred anywhere"/>
  <result pre="â€œCOVID toes.â€� These skin findings occurred anywhere from days before" exact="respiratory" post="symptom onset to weeks after recovery, and predominantly in"/>
  <result pre="can be expanded during this COVID-19 pandemic to help identify" exact="disease" post="through cutaneous presentations. Keywords Coronavirus Pandemic Cutaneous Inflammation Background"/>
  <result pre="expanded during this COVID-19 pandemic to help identify disease through" exact="cutaneous" post="presentations. Keywords Coronavirus Pandemic Cutaneous Inflammation Background Members of"/>
  <result pre="to help identify disease through cutaneous presentations. Keywords Coronavirus Pandemic" exact="Cutaneous" post="Inflammation Background Members of the Coronaviridae (CoV) family are"/>
  <result pre="with a helical capsid. This enzoonotic virus can remain viably" exact="infectious" post="even after capsid destruction through its ability to replicate"/>
  <result pre="within the taxa (Brian and Baric, 2005). Notably, the severe" exact="acute" post="respiratory syndrome (SARS) CoV epidemic was thought to originate"/>
  <result pre="the taxa (Brian and Baric, 2005). Notably, the severe acute" exact="respiratory" post="syndrome (SARS) CoV epidemic was thought to originate in"/>
  <result pre="taxa (Brian and Baric, 2005). Notably, the severe acute respiratory" exact="syndrome" post="(SARS) CoV epidemic was thought to originate in bats,"/>
  <result pre="to originate in bats, with the civet cat being the" exact="intermediate" post="host prior to human infection (Guan et al., 2003)."/>
  <result pre="the civet cat being the intermediate host prior to human" exact="infection" post="(Guan et al., 2003). In 2007, Cheng et al."/>
  <result pre="of patients in Wuhan, Hubei Province, China, presented with severe" exact="atypical pneumonia," post="and experts named the illness coronavirus disease 2019 (COVID-19;"/>
  <result pre="with severe atypical pneumonia, and experts named the illness coronavirus" exact="disease" post="2019 (COVID-19; European Centre for Disease Prevention and Control,"/>
  <result pre="named the illness coronavirus disease 2019 (COVID-19; European Centre for" exact="Disease" post="Prevention and Control, 2020). Although the source of this"/>
  <result pre="Disease Prevention and Control, 2020). Although the source of this" exact="viral" post="outbreak remains elusive, the original 27 cases were linked"/>
  <result pre="to Southern Chinaâ€™s Wuhan Seafood Wholesale Market (European Centre for" exact="Disease" post="Prevention and Control, 2020). This market is known for"/>
  <result pre="public for consumption, which was speculated to include an unidentified" exact="intermediate" post="host for COVID-19. As in SARS-CoV, bats are understood"/>
  <result pre="indicating that each infected person is likely to pass the" exact="disease" post="to &amp;gt;3 people (Liu et al., 2020). Fear of"/>
  <result pre="two of four cases reported no contact with the Wuhan" exact="Central" post="Hospital or the aforementioned market (Rothe et al., 2020)."/>
  <result pre="a pandemic on March 11, 2020, with a global case" exact="total" post="of &amp;gt;100,000. As of July 21, 2020, the worldwide"/>
  <result pre="total of &amp;gt;100,000. As of July 21, 2020, the worldwide" exact="total" post="number of confirmed COVID-19 cases eclipsed 14.8 million with"/>
  <result pre="cases and deaths by March 31, 2020, and the current" exact="total" post="number of cases as of June 21, 2020 exceeds"/>
  <result pre="&amp;gt;140,000 deaths, with reports in all 50 states (Centers for" exact="Disease" post="Control and Prevention [CDC], 2020a). Fig. 1 COVID-19 longitudinal"/>
  <result pre="harbouring &amp;gt;3700 individuals. Cruise lines create the perfect environment for" exact="infection" post="to run rampant, as seen in the past with"/>
  <result pre="early. Clinical presentation Clinical symptoms of COVID-19 range from mild" exact="respiratory" post="illness to acute respiratory distress syndrome. The original cohort"/>
  <result pre="Clinical symptoms of COVID-19 range from mild respiratory illness to" exact="acute" post="respiratory distress syndrome. The original cohort of patients in"/>
  <result pre="symptoms of COVID-19 range from mild respiratory illness to acute" exact="respiratory" post="distress syndrome. The original cohort of patients in Wuhan"/>
  <result pre="Wuhan presented with fever, cough, and dyspnea along with corresponding" exact="chest" post="computed tomography imaging illustrating bilateral ground glass opacities and"/>
  <result pre="and dyspnea along with corresponding chest computed tomography imaging illustrating" exact="bilateral" post="ground glass opacities and a notable paucity of upper"/>
  <result pre="illustrating bilateral ground glass opacities and a notable paucity of" exact="upper respiratory tract infection" post="hallmarks (e.g., rhinorrhea, pharyngitis, or sinusitis; Assiri et al.,"/>
  <result pre="bilateral ground glass opacities and a notable paucity of upper" exact="respiratory" post="tract infection hallmarks (e.g., rhinorrhea, pharyngitis, or sinusitis; Assiri"/>
  <result pre="glass opacities and a notable paucity of upper respiratory tract" exact="infection" post="hallmarks (e.g., rhinorrhea, pharyngitis, or sinusitis; Assiri et al.,"/>
  <result pre="al., 2020, Lee et al., 2020). This rapid progression to" exact="acute" post="respiratory distress syndrome is believed to be a result"/>
  <result pre="2020, Lee et al., 2020). This rapid progression to acute" exact="respiratory" post="distress syndrome is believed to be a result of"/>
  <result pre="et al., 2020). This rapid progression to acute respiratory distress" exact="syndrome" post="is believed to be a result of the virus"/>
  <result pre="be a result of the virus homing in on the" exact="lower" post="respiratory epithelium for attachment and infection (Huang et al.,"/>
  <result pre="a result of the virus homing in on the lower" exact="respiratory" post="epithelium for attachment and infection (Huang et al., 2020)."/>
  <result pre="homing in on the lower respiratory epithelium for attachment and" exact="infection" post="(Huang et al., 2020). Researchers suggest that a relationship"/>
  <result pre="SARS CoV-2 and the previous SARS CoV-1 and Middle East" exact="respiratory" post="syndrome (MERS) CoV epidemics. All three diseases originate from"/>
  <result pre="CoV-2 and the previous SARS CoV-1 and Middle East respiratory" exact="syndrome" post="(MERS) CoV epidemics. All three diseases originate from the"/>
  <result pre="three diseases originate from the genus Betacoronovirus and spread through" exact="respiratory" post="droplets (Peeri et al., 2020). There is an 82%"/>
  <result pre="complication with COVID-19 and appears to be associated with severe" exact="disease" post="phenotype (Zhang et al., 2020). Published reported of skin"/>
  <result pre="began (Table 1). A Chinese study claimed &amp;lt;1% incidence of" exact="cutaneous" post="manifestations, whereas an Italian cohort reported &amp;gt;20%, suggesting presentational"/>
  <result pre="an early diagnosis of COVID-19 because they can simulate other" exact="infections" post="(Lu et al., 2020). One such case was presented"/>
  <result pre="One such case was presented as a patient with a" exact="petechial rash" post="who was given an original diagnosis of Dengue fever"/>
  <result pre="a petechial rash who was given an original diagnosis of" exact="Dengue" post="fever that was later confirmed to be COVID-19 (Joob"/>
  <result pre="(Joob and Wiwanitkit, 2020, Mungmungpuntipantip and Wiwanitkit, 2020). Table 1" exact="Cutaneous" post="manifestations of COVID-19. Presentation Description Literature Morbilliform rash Known"/>
  <result pre="Cutaneous manifestations of COVID-19. Presentation Description Literature Morbilliform rash Known" exact="viral" post="exanthem; Italian and Spanish cohorts described various rates of"/>
  <result pre="2020, Sachdeva et al., 2020, GalvÃ¡n Casas et al., 2020" exact="Urticaria" post="Cohorts in Spain and Italy presented with an urticarial"/>
  <result pre="Italy presented with an urticarial rash; many presented prior to" exact="respiratory" post="symptoms Tang et al., 2020, Bouaziz et al., 2020"/>
  <result pre="et al., 2020 Vesicular eruptions Chickenpox-like rash observed in a" exact="diffuse" post="pattern Tammaro et al., 2020 Acral pernio-like lesions Acral"/>
  <result pre="2020 Livedo reticularis Case reports in the United States of" exact="transient" post="Livedo reticularis eruption unilaterally; mechanism may be related to"/>
  <result pre="state Manalo et al., 2020 Petechial rash Case report of" exact="petechial rash" post="that can be mistaken for Dengue Joob and Wiwanitkit,"/>
  <result pre="Case report of petechial rash that can be mistaken for" exact="Dengue" post="Joob and Wiwanitkit, 2020 Drug reaction Drugs used to"/>
  <result pre="skin manifestations, with some studies identifying skin findings days before" exact="respiratory" post="signs and others weeks after recovery. Researchers speculate that"/>
  <result pre="skin findings are caused by an inflammatory response to the" exact="infection" post="that results in complement-mediated microvascular injury (Magro et al.,"/>
  <result pre="al., 2020). Some reports discuss the difficulty in confirming that" exact="cutaneous" post="manifestations are specific to SARS-CoV-2; many critically ill patients"/>
  <result pre="ill patients receive multiple medication regimens that can yield similar" exact="cutaneous" post="findings (Young and Fernandez, 2020). Although there is no"/>
  <result pre="Fernandez, 2020). Although there is no necessary treatment for COVID-related" exact="cutaneous" post="manifestations, dermatologists should follow American Academy of Dermatology guidance"/>
  <result pre="no necessary treatment for COVID-related cutaneous manifestations, dermatologists should follow" exact="American" post="Academy of Dermatology guidance when prescribing immunosuppressive agents for"/>
  <result pre="2020). Another novel phenomenon associated with COVID-19 is a Kawasaki-like" exact="syndrome" post="currently termed â€œhyperinflammatory shockâ€� or more specifically â€œpediatric inflammatory"/>
  <result pre="with high fevers, conjunctivitis, rash, and refractory shock with minimal" exact="respiratory" post="symptoms (Riphagen et al., 2020). Similar to classic Kawasakiâ€™s"/>
  <result pre="a delayed immune-mediated response in children with a history of" exact="infection" post="(Viner and Whittaker, 2020). Risk factors for adverse consequences"/>
  <result pre="(e.g., asthma, emphysema, and smoking) and those with comorbidities that" exact="lower" post="their overall health status (e.g., low vitamin D level,"/>
  <result pre="their overall health status (e.g., low vitamin D level, cancer," exact="renal disease," post="diabetes, and hypertension). Fang et al. (2020) suggest that"/>
  <result pre="and MERS combined (Mahase, 2020). Although COVID-19 has a significantly" exact="lower" post="case fatality rate than SARS CoV-1 (10%) and MERS"/>
  <result pre="early on to represent a unique factor with regard to" exact="susceptibility to" post="severe respiratory illness; Italy is known to have the"/>
  <result pre="represent a unique factor with regard to susceptibility to severe" exact="respiratory" post="illness; Italy is known to have the oldest European"/>
  <result pre="can be transferred through breastmilk. Breastfeeding mothers with a suspected" exact="infection" post="should continue to practice proper hygiene and wear a"/>
  <result pre="and wear a mask while breastfeeding to avoid transference of" exact="respiratory" post="particles (CDC, 2020d). Children and adolescents are susceptible to"/>
  <result pre="are in place for the adolescent population to protect against" exact="infection" post="and spread (Schmitt, 2020). Avoidance of ibuprofen and other"/>
  <result pre="patients who took NSAIDs before becoming ill experienced more severe" exact="pneumonia" post="than those who had not (Day, 2020). However, multiple"/>
  <result pre="the angiotensin converting enzyme 2 receptor (ACE2) serves as the" exact="infective" post="portal of entry (Cai, 2020, Letko and Munster, 2020,"/>
  <result pre="2020). Downregulation of ACE2 leads to downstream effects, including upregulating" exact="type 1A" post="ACE2 receptors, and results in increased pulmonary vascular permeability"/>
  <result pre="including upregulating type 1A ACE2 receptors, and results in increased" exact="pulmonary" post="vascular permeability (Imai et al., 2005). Containment and quarantine"/>
  <result pre="upregulating type 1A ACE2 receptors, and results in increased pulmonary" exact="vascular" post="permeability (Imai et al., 2005). Containment and quarantine The"/>
  <result pre="off port for 40â€¯days in an effort to prevent the" exact="plague" post="from entering mainland (CDC, 2020e). The bubonic plague of"/>
  <result pre="to prevent the plague from entering mainland (CDC, 2020e). The" exact="bubonic plague" post="of the 14th century, also referred to as the"/>
  <result pre="prevent the plague from entering mainland (CDC, 2020e). The bubonic" exact="plague" post="of the 14th century, also referred to as the"/>
  <result pre="plague of the 14th century, also referred to as the" exact="black death" post="pandemic, accounted for an estimated 50 to 100 million"/>
  <result pre="perspective, approximately 60% of Europeâ€™s population was decimated by the" exact="disease" post="(McEvedy, 1988). The responsible bacterium, Yersinia pestis, causes a"/>
  <result pre="was decimated by the disease (McEvedy, 1988). The responsible bacterium," exact="Yersinia pestis," post="causes a prodrome stage of myalgias, fever, and shortness"/>
  <result pre="(Cui and Song, 2016). The most lethal form of the" exact="plague" post="is spread through respiratory droplets from human-to-human transmission, resulting"/>
  <result pre="The most lethal form of the plague is spread through" exact="respiratory" post="droplets from human-to-human transmission, resulting in a pneumonic plague"/>
  <result pre="through respiratory droplets from human-to-human transmission, resulting in a pneumonic" exact="plague" post="that reaches a near 100% fatality rate (CDC, 2018)."/>
  <result pre="flu was due in part to three distinct waves of" exact="disease" post="(Grabowski et al., 2017). The first wave took place"/>
  <result pre="spring of 1919. The WHO defines a pandemic as an" exact="infection" post="that is able to sustain infectivity and spread across"/>
  <result pre="response for rapid intervention has focused on containment (WHO, 2020)." exact="Infectious" post="diseases start out as endemics, meaning they infect a"/>
  <result pre="as endemics, meaning they infect a particular subpopulation at a" exact="stable" post="and predictable rate (Grennan, 2019). When the infection progresses"/>
  <result pre="at a stable and predictable rate (Grennan, 2019). When the" exact="infection" post="progresses to spread at an unpredictable rate, the disease"/>
  <result pre="the infection progresses to spread at an unpredictable rate, the" exact="disease" post="is classified as an outbreak. Outbreaks evolve into epidemics"/>
  <result pre="phases 1 through 3, which are defined as mostly animal" exact="infections" post="with a few human cases (WHO, 2020). Phase 4"/>
  <result pre="and cruise ships) are associated with the highest risk of" exact="infection" post="because they take place in generally highly concentrated areas"/>
  <result pre="Individuals who believe they have contracted COVID-19 but are clinically" exact="stable" post="should remain at home and self-quarantine for 14â€¯days minimum"/>
  <result pre="reduces the risk of infecting the individuals at hospitals with" exact="chronic" post="illness who are the most susceptible to severe respiratory"/>
  <result pre="with chronic illness who are the most susceptible to severe" exact="respiratory" post="failure and alleviates the burden of overwhelming hospital personnel."/>
  <result pre="Administration, 2019). Alternatively, hand sanitizer can be effective in the" exact="absence of" post="soap and water, such as in public forums. All"/>
  <result pre="contact with others (e.g., groceries, gas, work) CDC, Centers for" exact="Disease" post="Control and Prevention. Table 3 Social distancing protocol to"/>
  <result pre="social distancing Maintain proper hygiene by using disposable tissues or" exact="upper" post="arm to cover sneeze or cough. Avoid touching unnecessary"/>
  <result pre="soap and water or hand sanitizer often. CDC, Centers for" exact="Disease" post="Control and Prevention. Fear of contracting COVID-19 has led"/>
  <result pre="masks have been shown to be similarly effective in preventing" exact="infection" post="in lower-risk situations, such as outdoor areas, because they"/>
  <result pre="Treatment and management Supportive care is the mainstay treatment for" exact="respiratory" post="distress in COVID-19, encompassing ventilation support and extracorporeal membrane"/>
  <result pre="of possible therapeutic regimens. Treatment horizons Two previous trials of" exact="systemic" post="corticosteroids to address the high cytokine load did not"/>
  <result pre="did not improve mortality and instead caused a delay in" exact="viral" post="clearance (Arabi et al., 2018, Stockman et al., 2006)."/>
  <result pre="researchers suggest a trial of antiviral medications to help suppress" exact="viral" post="replication, and both ritonavir and lopinavir are being studied"/>
  <result pre="shortening the time until clinical improvement in patients with COVID-19" exact="infection" post="(Grein et al., 2020). Hydroxychloroquine, a disease-modifying antirheumatic drug,"/>
  <result pre="and DÃ¶rner, 2020). This agent provides a similar benefit in" exact="systemic" post="lupus erythematous by attenuating the proinflammatory cascade (Tang et"/>
  <result pre="DÃ¶rner, 2020). This agent provides a similar benefit in systemic" exact="lupus" post="erythematous by attenuating the proinflammatory cascade (Tang et al.,"/>
  <result pre="associated with inflammation and leukocyte recruitment and could potentially reduce" exact="respiratory" post="distress. Another promising and emerging area of investigation is"/>
  <result pre="The mechanism of action works through the interference of RNA" exact="viral" post="replication (te Velthuis et al., 2010). No vaccine to"/>
  <result pre="has emerged as the singular frontrunner in the treatment of" exact="symptomatic" post="patients. Supportive care remains the mainstay of treatment as"/>
  <result pre="patients. Supportive care remains the mainstay of treatment as the" exact="total" post="case number continues to increase. Reports on cutaneous manifestations"/>
  <result pre="as the total case number continues to increase. Reports on" exact="cutaneous" post="manifestations of COVID-19, ranging from maculopapular exanthems to acral"/>
  <result pre="with the ethical approval of all relevant bodies. References References" exact="American" post="Academy of Dermatology. Guidance on the use of immunosuppressive"/>
  <result pre="https://www.aad.org/member/practice/coronavirus/clinical-guidance/biologics. ArabiY.M.MandourahY.Al-HameedF.SindiA.A.AlmekhlafiG.A.HusseinM.A.Corticosteroid therapy for critically ill patients with Middle East" exact="respiratory" post="syndromeAm J Respir Crit Care Med197201875776729161116 AssiriA.Al-TawfiqJ.A.Al-RabeeahA.A.Al-RabiahF.A.Al-HajjarS.Al-BarrakA.Epidemiological, demographic, and"/>
  <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive studyLancet"/>
  <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
  <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 BernheimA.MeiX.HuangM.YangY.FayadZ.A.ZhangN.Chest"/>
  <result pre="Jachiet M, Velter C, Lestang P, Cassius C, et al." exact="Vascular" post="skin symptoms in COVID-19: a French observational study. J"/>
  <result pre="2020 [cited 2020 March 1]. Available from: https://www.genemedi.net/i/comparison-between-covid-19-and-sars-ncov-in-pathology-pathogenesis Centers for" exact="Disease" post="Control and Prevention. Coronavirus disease 2019 situation summary [Internet]."/>
  <result pre="Available from: https://www.genemedi.net/i/comparison-between-covid-19-and-sars-ncov-in-pathology-pathogenesis Centers for Disease Control and Prevention. Coronavirus" exact="disease" post="2019 situation summary [Internet]. 2020a [cited 2020 March 1]."/>
  <result pre="2020a [cited 2020 March 1]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html Centers for" exact="Disease" post="Control and Prevention. Interim guidance for ships on managing"/>
  <result pre="and Prevention. Interim guidance for ships on managing suspected coronavirus" exact="disease" post="2019 [Internet]. 2020b [cited 2020 March 13]. Available from:"/>
  <result pre="2020b [cited 2020 March 13]. Available from: https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html Centers for" exact="Disease" post="Control and Prevention. Coronavirus disease 2019 (COVID-19) guidance for"/>
  <result pre="Available from: https://www.cdc.gov/quarantine/maritime/recommendations-for-ships.html Centers for Disease Control and Prevention. Coronavirus" exact="disease" post="2019 (COVID-19) guidance for ships [Internet]. 2020c [cited 2020"/>
  <result pre="2020c [cited 2020 March 16]. Available from: https://www.cdc.gov/quarantine/cruise/index.html Centers for" exact="Disease" post="Control and Prevention. If you are pregnant, breastfeeding, or"/>
  <result pre="2020d [cited 2020 July 21]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnancy-breastfeeding.html Centers for" exact="Disease" post="Control and Prevention. Quarantine and isolation [Internet]. 2020e [cited"/>
  <result pre="[cited 2020 March 8, 2020]. Available from: https://www.cdc.gov/quarantine/historyquarantine.html Centers for" exact="Disease" post="Control and Prevention. Quarantine and isolation [Internet]. 2018 [cited"/>
  <result pre="2018 [cited 2020 March 17]. Available from: https://www.cdc.gov/plague/symptoms/index.html Centers for" exact="Disease" post="Control and Prevention. Coronavirus disease 2019 (COVID19): Travel [Internet]."/>
  <result pre="Available from: https://www.cdc.gov/plague/symptoms/index.html Centers for Disease Control and Prevention. Coronavirus" exact="disease" post="2019 (COVID19): Travel [Internet]. 2020f [cited 2020 April 11]."/>
  <result pre="2020f [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html Centers for" exact="Disease" post="Control and Prevention. Coronavirus and travel in the United"/>
  <result pre="2020g [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/travel-in-the-us.html Centers for" exact="Disease" post="Control and Prevention. Social distancing, quarantine and isolation [Internet]."/>
  <result pre="2020h [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/social-distancing.html Centers for" exact="Disease" post="Control and Prevention. Use of cloth face coverings to"/>
  <result pre="[Internet]. 2020i [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html ChengV.C.LauS.K.WooP.C.YuenK.Y.Severe" exact="acute" post="respiratory syndrome coronavirus as an agent of emerging and"/>
  <result pre="2020i [cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html ChengV.C.LauS.K.WooP.C.YuenK.Y.Severe acute" exact="respiratory" post="syndrome coronavirus as an agent of emerging and reemerging"/>
  <result pre="[cited 2020 April 11]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/diy-cloth-face-coverings.html ChengV.C.LauS.K.WooP.C.YuenK.Y.Severe acute respiratory" exact="syndrome" post="coronavirus as an agent of emerging and reemerging infectionClin"/>
  <result pre="symptoms, say doctors and scientistsBMJ3682020m108632184201 DerrickJ.L.GomersallC.D.Protecting healthcare staff from severe" exact="acute" post="respiratory syndrome: filtration capacity of multiple surgical masksJ Hosp"/>
  <result pre="say doctors and scientistsBMJ3682020m108632184201 DerrickJ.L.GomersallC.D.Protecting healthcare staff from severe acute" exact="respiratory" post="syndrome: filtration capacity of multiple surgical masksJ Hosp Infect594200536536815749326"/>
  <result pre="patientsProc Natl Acad Sci U S A2020202004168 European Centre for" exact="Disease" post="Prevention and Control. Risk assessment: Outbreak of acute respiratory"/>
  <result pre="Centre for Disease Prevention and Control. Risk assessment: Outbreak of" exact="acute" post="respiratory syndrome associated with a novel coronavirus, Wuhan, China;"/>
  <result pre="for Disease Prevention and Control. Risk assessment: Outbreak of acute" exact="respiratory" post="syndrome associated with a novel coronavirus, Wuhan, China; first"/>
  <result pre="Disease Prevention and Control. Risk assessment: Outbreak of acute respiratory" exact="syndrome" post="associated with a novel coronavirus, Wuhan, China; first update."/>
  <result pre="first update. Stockholm: ECDC; January 22, 2020. FangL.KarakiulakisG.RothM.Are patients with" exact="hypertension" post="and diabetes mellitus at increased risk for COVID-19 infection?Lancet"/>
  <result pre="Stockholm: ECDC; January 22, 2020. FangL.KarakiulakisG.RothM.Are patients with hypertension and" exact="diabetes mellitus" post="at increased risk for COVID-19 infection?Lancet Respir MedS2213â€&quot;26002020203011630118 FauciA.S.LaneH.C.RedfieldR.R.Covid-19"/>
  <result pre="Mil Vet health2020121116 GalvÃ¡n CasasC.CatalÃ A.Carretero HernÃ¡ndezG.RodrÃ­guez-JimÃ©nezP.FernÃ¡ndez-NietoD.RodrÃ­guez-Villa LarioA.Classification of the" exact="cutaneous" post="manifestations of COVID-19: a rapid prospective nationwide consensus study"/>
  <result pre="A, Adami G, Gatti D, Idolazzi L, Rossini M. Coronavirus" exact="disease" post="19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID). Ann Rheum"/>
  <result pre="J Med3822420202327233632275812 GrennanD.What is a pandemic?JAMA3219201991030835310 GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN Engl J Med3821820201708172032109013 GuanY.ZhengB.J.HeY.Q.LiuX.L.ZhuangZ.X.CheungC.L.Isolation and characterization"/>
  <result pre="coronavirus in Wuhan, ChinaLancet39510223202049750631986264 ImaiY.KubaK.RaoS.HuanY.GuoF.GuanB.Angiotensin-converting enzyme 2 protects from severe" exact="acute" post="lung failureNature4367047200511211616001071 JoobB.WiwanitkitV.COVID-19 can present with a rash and"/>
  <result pre="Chen J, et al. Alert for non-respiratory symptoms of Coronavirus" exact="Disease" post="2019 (COVID-19) patients in epidemic period: A case report"/>
  <result pre="2019 (COVID-19) patients in epidemic period: A case report of" exact="familial" post="cluster with three asymptomatic COVID-19 patients. J Med Virol"/>
  <result pre="2020 [Epub ahead of publication]. MagroC.MulveyJ.J.BerlinD.NuovoG.SalvatoreS.HarpJ.Complement associated microvascular injury and" exact="thrombosis" post="in the pathogenesis of severe COVID-19 infection: a report"/>
  <result pre="has killed more people than SARS and MERS combined, despite" exact="lower" post="case fatality rateBMJ3682020m64132071063 ManaloI.F.SmithM.K.CheeleyJ.JacobsR.A dermatologic manifestation of COVID-19: Transient"/>
  <result pre="despite lower case fatality rateBMJ3682020m64132071063 ManaloI.F.SmithM.K.CheeleyJ.JacobsR.A dermatologic manifestation of COVID-19:" exact="Transient" post="livedo reticularisJ Am Acad DermatolS0190â€&quot;96222020203055830562 McEvedyC.The bubonic plagueSci Am258219881181233055286"/>
  <result pre="in pregnancy and delivery: rapid reviewUltrasound Obstet Gynecol555202058659232180292 MungmungpuntipantipR.WiwanitkitV.COVID-19 and" exact="cutaneous" post="manifestationsJ Eur Acad Dermatol Venereol3462020e246 PattersonK.PyleG.The geography and mortality"/>
  <result pre="LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral" exact="cutaneous" post="lesions in the time of COVID-19. J Eur Acad"/>
  <result pre="[cited 2020 March 17]. Available from: https://www.nih.gov/news-events/news-releases/nih-clinical-trial-investigational-vaccine-covid-19-begins RotheC.SchunkM.SothmannP.BretzelG.FroeschlG.WallrauchC.Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med38210202097097132003551"/>
  <result pre="review of literatureJ Dermatol Sci9822020758132381430 Schmitt B. Coronavirus (COVID-19) exposure." exact="Pediatric" post="2020 [Epub ahead of publication]. SchrezenmeierE.DÃ¶rnerT.Mechanisms of action of"/>
  <result pre="Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J." exact="Cutaneous" post="manifestations in COVID-19: The experiences of Barcelona and Rome."/>
  <result pre="Wang Y, Zhang H, Zheng Q, Fang R, Sun Q." exact="Cutaneous" post="manifestations of the Coronavirus Disease 2019 (COVID-19): A brief"/>
  <result pre="Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus" exact="Disease" post="2019 (COVID-19): A brief review. Dermatol Ther 2020 [Epub"/>
  <result pre="landscapeNat Rev Drug Discov195202030530632273591 U.S Food and Drug Administration. Coronavirus" exact="Disease" post="2019 (COVID-19) [Internet]. 2020 [cited 2020 March 8]. Available"/>
  <result pre="Emerging complication during the COVID-19 pandemicLancet3951023920201741174332410759 World Health Organization. Coronavirus" exact="disease" post="(COVID-19) travel advice [Internet]. 2020 [cited 2020 March 8]."/>
  <result pre="8]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature5797798202026526932015508 WuP.HaoX.LauE.H.Y.WongJ.Y.LeungK.S.M.WuJ.T.Real-time tentative assessment of the epidemiological"/>
  <result pre="Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature5797798202026526932015508 WuP.HaoX.LauE.H.Y.WongJ.Y.LeungK.S.M.WuJ.T.Real-time tentative assessment of the epidemiological characteristics"/>
  <result pre="WuP.HaoX.LauE.H.Y.WongJ.Y.LeungK.S.M.WuJ.T.Real-time tentative assessment of the epidemiological characteristics of novel coronavirus" exact="infections" post="in Wuhan, China, as at 22 January 2020Euro Surveill25320202000044"/>
  <result pre="have failed low-dose therapyPreprints20202020030065 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med3828202072773331978945"/>
 </snippets>
</snippetsTree>
